Differential Associations of Cigar, Pipe, and Smokeless Tobacco Use Versus Combustible Cigarette Use With Subclinical Markers of Inflammation, Thrombosis, and Atherosclerosis: The Cross-Cohort Collaboration–Tobacco Working Group

Use of noncigarette tobacco products is linked to subclinical markers related to cardiovascular harm. Inflammatory markers, such as high-sensitivity C-reactive protein and interleukin-6, have the potential for assessing early cardiovascular harm from using these products and aiding regulatory authorities in evaluating their associated risks.

Authors

Institutions

Publication Details

Journal
Circulation
Published
2025-01-27
DOI
https://doi.org/10.1161/circulationaha.124.070852
Citations
6
Primary Topic
Cardiovascular Disease and Adiposity
Type
article
Field-Weighted Citation Impact
8.33
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Differential Associations of Cigar, Pipe, and Smokeless Tobacco Use Versus Combustible Cigarette Use With Subclinical Markers of Inflammation, Thrombosis, and Atherosclerosis: The Cross-Cohort Collaboration–Tobacco Working Group

Ramachandran Srini Vasan, Michael Joseph Blaha, Aruni Bhatnagar, Amit Khera et al.
6 citations
Circulation
Cardiovascular Disease and Adiposity
8.33
article

Differential Associations of Cigar, Pipe, and Smokeless Tobacco Use Versus Combustible Cigarette Use With Subclinical Markers of Inflammation, Thrombosis, and Atherosclerosis: The Cross-Cohort Collaboration–Tobacco Working Group

Ramachandran Srini Vasan, Michael Joseph Blaha, Aruni Bhatnagar, Amit Khera, Andrew P. DeFilippis, Zeina Dardari, Erfan Tasdighi, João A.C. Lima, Ellen Boakye, Tanuja Rajan, Lawrence J. Appel, Debbie L. Cohen, Carlos J. Rodríguez, Michael E. Hall, Ngozi Osuji, Emelia J. Benjamin, Kunal Jha, Shelley A. Cole, Suzanne E. Judd, Zhiqi Yao, Kunihiro Matsushita, Rachel Widome, Eleanor Marie Simonsick
article en
6 citations

Abstract

Use of noncigarette tobacco products is linked to subclinical markers related to cardiovascular harm. Inflammatory markers, such as high-sensitivity C-reactive protein and interleukin-6, have the potential for assessing early cardiovascular harm from using these products and aiding regulatory authorities in evaluating their associated risks.

CirculationVol. 151(14)
Boston University (US), American Heart Association (US), Texas Biomedical Research Institute (US), Albert Einstein College of Medicine (US), University of Minnesota (US), University of Louisville (US), Johns Hopkins University (US), The University of Texas at San Antonio Health Science Center (US), Johns Hopkins Medicine (US), University of Mississippi Medical Center (US), University of Alabama at Birmingham (US), National Institute on Aging (US), Minnesota Department of Health (US), The University of Texas at San Antonio (US), University of Pennsylvania (US), The University of Texas Southwestern Medical Center (US), Vanderbilt University Medical Center (US)
Good health and well-being
Openalex Percentile: Top 2%
Cardiovascular Disease and Adiposity
8.33
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.